久光製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2022/01/25 | 3,575 | 3,600 | 3,535 | 3,590 | -10 | -0.3% | 232,700 |
2022/01/24 | 3,505 | 3,600 | 3,475 | 3,600 | +75 | +2.1% | 283,100 |
2022/01/21 | 3,410 | 3,525 | 3,405 | 3,525 | +80 | +2.3% | 267,200 |
2022/01/20 | 3,360 | 3,460 | 3,360 | 3,445 | +45 | +1.3% | 324,100 |
2022/01/19 | 3,415 | 3,450 | 3,390 | 3,400 | -70 | -2% | 290,900 |
2022/01/18 | 3,565 | 3,620 | 3,470 | 3,470 | -120 | -3.3% | 381,700 |
2022/01/17 | 3,650 | 3,660 | 3,575 | 3,590 | -45 | -1.2% | 343,000 |
2022/01/14 | 3,830 | 3,855 | 3,620 | 3,635 | -405 | -10% | 845,900 |
2022/01/13 | 4,180 | 4,180 | 4,035 | 4,040 | -140 | -3.3% | 333,400 |
2022/01/12 | 4,100 | 4,195 | 4,085 | 4,180 | +120 | +3% | 292,200 |
2022/01/11 | 4,120 | 4,150 | 4,015 | 4,060 | -25 | -0.6% | 257,600 |
2022/01/07 | 4,025 | 4,090 | 4,000 | 4,085 | +105 | +2.6% | 261,800 |
2022/01/06 | 4,080 | 4,120 | 3,980 | 3,980 | -135 | -3.3% | 297,600 |
2022/01/05 | 4,130 | 4,140 | 4,085 | 4,115 | -25 | -0.6% | 223,700 |
2022/01/04 | 4,045 | 4,145 | 4,015 | 4,140 | +165 | +4.2% | 352,900 |
2021/12/30 | 4,040 | 4,050 | 3,965 | 3,975 | -100 | -2.5% | 243,600 |
2021/12/29 | 4,070 | 4,120 | 4,050 | 4,075 | ±0 | ±0% | 155,400 |
2021/12/28 | 4,070 | 4,115 | 4,040 | 4,075 | ±0 | ±0% | 202,800 |
2021/12/27 | 4,045 | 4,085 | 3,980 | 4,075 | +30 | +0.7% | 215,500 |
2021/12/24 | 4,030 | 4,055 | 3,970 | 4,045 | +25 | +0.6% | 204,000 |
2021/12/23 | 4,060 | 4,080 | 4,005 | 4,020 | -35 | -0.9% | 157,800 |
2021/12/22 | 4,080 | 4,110 | 4,030 | 4,055 | +30 | +0.7% | 262,800 |
2021/12/21 | 3,970 | 4,030 | 3,960 | 4,025 | +85 | +2.2% | 223,900 |
2021/12/20 | 4,000 | 4,005 | 3,925 | 3,940 | -65 | -1.6% | 205,700 |
2021/12/17 | 4,055 | 4,075 | 4,005 | 4,005 | -80 | -2% | 606,000 |
2021/12/16 | 4,105 | 4,115 | 4,065 | 4,085 | +60 | +1.5% | 299,900 |
2021/12/15 | 4,075 | 4,155 | 4,025 | 4,025 | -85 | -2.1% | 320,300 |
2021/12/14 | 3,995 | 4,120 | 3,990 | 4,110 | +100 | +2.5% | 367,400 |
2021/12/13 | 3,920 | 4,020 | 3,920 | 4,010 | +110 | +2.8% | 272,500 |
2021/12/10 | 3,920 | 3,960 | 3,880 | 3,900 | -20 | -0.5% | 273,600 |
2021/12/09 | 4,000 | 4,010 | 3,915 | 3,920 | -120 | -3% | 296,700 |
2021/12/08 | 3,950 | 4,050 | 3,930 | 4,040 | +150 | +3.9% | 360,500 |
2021/12/07 | 3,885 | 3,910 | 3,805 | 3,890 | +40 | +1% | 445,100 |
2021/12/06 | 3,955 | 3,995 | 3,850 | 3,850 | -105 | -2.7% | 361,900 |
2021/12/03 | 3,825 | 3,965 | 3,790 | 3,955 | +110 | +2.9% | 453,500 |
2021/12/02 | 3,935 | 4,010 | 3,845 | 3,845 | -105 | -2.7% | 451,800 |
2021/12/01 | 3,935 | 4,030 | 3,870 | 3,950 | -40 | -1% | 783,200 |
2021/11/30 | 3,915 | 4,005 | 3,895 | 3,990 | +40 | +1% | 4,659,000 |
2021/11/29 | 3,860 | 3,965 | 3,860 | 3,950 | +10 | +0.3% | 647,600 |
2021/11/26 | 3,895 | 3,955 | 3,840 | 3,940 | -5 | -0.1% | 526,000 |
2021/11/25 | 3,960 | 3,965 | 3,895 | 3,945 | +25 | +0.6% | 309,900 |
2021/11/24 | 4,000 | 4,005 | 3,895 | 3,920 | -105 | -2.6% | 472,400 |
2021/11/22 | 3,960 | 4,055 | 3,920 | 4,025 | +10 | +0.2% | 359,600 |
2021/11/19 | 4,040 | 4,080 | 3,965 | 4,015 | -55 | -1.4% | 364,700 |
2021/11/18 | 4,070 | 4,130 | 4,035 | 4,070 | -55 | -1.3% | 361,200 |
2021/11/17 | 4,090 | 4,155 | 4,060 | 4,125 | +10 | +0.2% | 342,000 |
2021/11/16 | 4,115 | 4,160 | 4,065 | 4,115 | +10 | +0.2% | 472,100 |
2021/11/15 | 4,010 | 4,125 | 4,010 | 4,105 | +80 | +2% | 407,800 |
2021/11/12 | 3,930 | 4,055 | 3,930 | 4,025 | +85 | +2.2% | 698,000 |
2021/11/11 | 3,865 | 3,955 | 3,840 | 3,940 | +80 | +2.1% | 368,900 |
801~
850
件表示中 / 3692件
類似銘柄と比較する
現在ご覧いただいている「久光薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
久光薬 | 443,700円 | +5.8% | +1.2% | 2.70% | 14.72倍 | 1.17倍 |
|
貼る鎮痛消炎剤首位。医療用シェア5割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
ロート | 241,800円 | +18.2% | +4.2% | 1.49% | 16.97倍 | 2.16倍 |
|
一般用医薬品の目薬で世界首位。「肌研」が急成長しスキンケアが柱に。アジアなど海外積極進出 |
参天薬 | 147,400円 | 0.0% | +50.6% | 2.44% | 15.48倍 | 1.74倍 |
|
緑内障、加齢黄斑変性、ドライアイ治療薬など眼科用医薬品首位。一般用目薬「サンテ」が有名 |
住友ファーマ | 94,100円 | +26.8% | - | 0.00% | 15.84倍 | 3.27倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
ツムラ | 430,100円 | +20.9% | +87.3% | 3.16% | 9.61倍 | 1.11倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
市場注目の銘柄
チャート関連のコラム